Rapamycin and Chloroquine Modulate Insulin Resistance and Hepatic Stea

Introduction

In recent years, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as MAFLD/NAFLD) has emerged as a major global public health challenge. Epidemiological data indicate that MASLD currently affects over…